Tag: CYTX

Blue Horseshoe Stocks: Fresh Options Ideas & More

Pazoo Inc. PZOO

PZOO has been progressing well in the past several sessions since we last touched base with the stock a couple of weeks ago. We had just received word from the company that its wholly-owned CannabisKing Distribution subsidiary had struck two significant deals (Links to PR’s below), and witnessed a two-session swing of 74% as a result.

After regrouping and bouncing off of a low of .0046 (07/13), PZOO has made continuously higher lows for the rest of this month, and pushed its PPS back to the current range (.006-.007). We’ve provided the following snapshot illustrating the current bullish characteristics of the chart.

We’ll be on the lookout for further updates regarding the many irons PZOO currently has in the fire, and you can be sure that we’ll pass them along as the stories develop.

Fresh Options Ideas

As we approach midweek with earnings drops in full swing, we’re going to formulate a few corresponding options ideas we feel have the potential to perform well:

Ford Motor Co. (F) – Ford set record North American profits and beat Wall St. expectations handily this morning. The stock is gapping up moderately, so we’re going to taking a look at F Weekly $14.50 and $15 Calls, which should produce some nice action.

Pfizer, Inc. PFE –  Pfizer also had an earnings beat on their Q2 release today, and our related options ideas will be to monitor PFE Weekly $34.50 and $35 Calls.

Baidu, Inc. BIDU – After an extreme analyst downgrade, BIDU is taking an absolute beating, and is leading us to include a rare idea on the bearish side of things; we’ll be tracking BIDU Weekly Puts in the $180-175 Range.

Cytori Therapeutics, Inc. CYTX

We also want to raise a flag on a familiar stock cropping up in the news feed this morning. Early this year we saw CYTX make a huge move, and after spending the last several months in a general downtrend, some FDA-related news out this morning could be just the thing to catalyze a reversal. We’ll be watching intently for that possibility; check out the news below.

Cytori Therapeutics, Inc. (CYTX) today announced that Kerastem Technologies, a wholly owned subsidiary of Bimini Technologies, received U.S. Food and Drug Administration (FDA) conditional Investigational Device Exemption (IDE) approval to conduct a clinical trial studying the safety and feasibility of its technology for the treatment of female and early male pattern baldness (androgenic alopecia). >> FULL PR

Extended Watchlist:
PGNX, SDRL, NYMX, AKS, RJET

Blue Horseshoe Stocks: LNKD Options Update & More

LinkedIn Corp. LNKD – Options

A week ago today, we formulated some options ideas for LNKD including a range of longer-term contracts for our watchlist, specifically August $220.00-230.00 Calls. This morning we wanted to give an update on the trading ranges of those contracts and the opportunities they have afforded us thus far.

08/21 $220 Calls – Range: 9.80-14.30 – Max Gain: 46%
08/21 $225 Calls – Range: 8.02-11.30 – Max Gain: 41%
08/21 $230 Calls – Range: 5.10-9.35 – Max Gain: 83%

We want to keep in mind that we essentially have all summer to continue monitoring these contracts. The swings we’ve seen up to this point could just be the tip of the iceberg, so we won’t let LNKD slip off of our radars. The stock has been on a steady rebound from recent lows since the end of May. We’ll be looking for it to continue to building the chart with higher highs and higher lows; key resistance is presently sitting at the 50DMA of 226.39.

Medican Enterprises, Inc. MDCN

We also need to remind our readers of a recent bottom-watch call we made in the form of MDCN. This cannabis-related play has appeared in our reports several times; most recently on May 26th. At the time we mentioned that the stock was searching for support after a months-long downtrend, and that we felt the possibility of a rebound was forthcoming.

While it took several sessions to occur, MDCN finally found its legs yesterday with an 85% swing from .0013-.0024. It closed with strength, maintaining more than 50% of its daily gains on heavy volume, so we’ll definitely continue to observe the action here for the possibility of a multi-day run.

TapImmune, Inc. TPIV

Another stock that we tagged earlier this spring has been making serious moves. Just to update, we tagged TPIV on April 16th and at the time the stock was trading below .20. Since then, it has increased more than three-fold, now pushing its way up into the mid-.80’s.

This stock could produce ample bounce-play opportunities when it finally does consolidate off of this latest run-up, so we’ll put it on closer watch into next week.

Extended Watchlist:
CTIC, BLDP, CYTX, MNKD, CANF

Blue Horseshoe Stocks: Earnings-Related Options Ideas & More

Earnings-Related Options Ideas

We’ve entered into another round of high-profile earnings releases, and as our routine readers are well aware, this has become a key device in our seeking of quick-strike profits with options trading.

Ebay, Inc. EBAY
On EBAY, we’re going to size up contracts in the $58.50-60 Call range, looking for a classic dip-and-rip scenario. Usually on a gap-up after an earnings beat we see profit-taking which leads to a pullback followed by a resulting bounce. We look to get positioned in some in-the-money calls on the pullback that we can unload when the rebound occurs.

Caterpillar, Inc. CAT
CAT beat on earnings as well, and the range of contracts that we’re most likely going to find the biggest chances for gains here, should fall between $86-89.  We want to stay in the money with our strike price and roll it up in the event the stock breaks out more sharply.

Petroleo Brasiliero S.A. (Petrobras) PBR

For PBR, which is sliding back following yesterday’s post-market earnings release, we’re going to look for possible opportunities in Weekly Puts in the $9.00-8.50 range, depending on the intensity of the downward pressure we see on the stock as the market opens.

Enzon Pharmceuticals, Inc. ENZN

This is a stock that we want to put on our radars as we head into week’s end; biopharmas have been hot, and ENZN is among those that have been breaking out. We’re anxious to see how this play will continue to fare as it has been streaking into the blue sky.

It’s much like the move we saw in the past couple of weeks from VLTC, which spiked on news of an increased stake by billionaire activist investor Carl Icahn. It so happens that Icahn also owns shares in ENZN, which makes for an interesting side note. We’ll certainly want to keep this one in our sights moving forward.

Yahoo, Inc. YHOO – Options Ideas

If you recall, we were sitting on the fence with our approach to YHOO options yesterday as the internet search giant had fallen short on earnings. We noted that the heaviest action would likely be in the  $44-45 Calls or Puts, depending on the tone of the trend.

It became quickly apparent that YHOO was pulling back further upon the open,and anyone who followed our idea and latched onto the $44 Puts were in for quite a ride as those contracts traded in a range from .17-.55; an intraday swing of 223% The $45 Puts also made a move from .56-1.29, a slightly more subdued yet still very respectable 130%

Great Basin Scientific, Inc. GBSN

We need to congratulate anyone who caught our flag of GBSN in yesterday’s premarket report, as the stock made a healthy intraday run from 4.60-6.10 that could have afforded traders gains of up to 33% on the day on the heels of some FDA-related news.

Extended Watchlist:
CYTX, BTU, SCYX, IBIO